You are here

Bioiberica presented Condrovet® Force HA, Impromune and Atopivet in Portugal

28 Feb 2018
Companion Animal Health

The 14th meeting of the Montenegro Veterinary Hospital, held on 24-25 February 2018, was attended by more than 3,000 visitors

The latest Bioiberica product for joint care in cats and dogs, Condrovet® Force HA, raised great interest at the annual meeting hosted by the Montenegro Veterinary  Hospital. This meeting was held on 24-25 February 2018 at the Europarque venue in Santa Maria da Feira (Portugal). Hundreds of veterinarians visited Bioiberica’s booth to learn more about our new chondroprotector that includes exclusive ingredients such as Mobilee®, b-2Cool® and CS b-Bioactive®. It has the potential to be the most complete therapeutic tool for the treatment of canine and feline osteoarthritis, as well as for the management of degenerative conditions of the joint cartilage caused by age, being overweight or excessive exercise.

Our booth also presented Atopivet® capsules, our treatment for dogs with atopic dermatitis, and clinical trials on the use of Impromune in leishmaniasis. 

This year’s congress was attended by more than 3,000 visitors and 34 renowned international speakers. It was sponsored by leading firms within the veterinary sector such as Bioiberica.

Related News

25 Jan 2021
Companion Animal Health
  • The product is a supplementary food recommended to nurture growing joints in puppies, principally for fast-growing large breeds and in breeds predisposed to hip dysplasia
  • This is the third launch for the joint health area in the last three years, which renews the entire line.
30 Nov 2020
Companion Animal Health
  • This dietary supplement is recommended to protect the joints of large dog breeds
  • The product stands out for its great palatability, convenient dosage and unique composition on the market
14 Sep 2020
Companion Animal Health
  • This completes its Atopivet® range of dermatological products, both orally and topically, which help maintain the skin's integrity and protective barrier
  • There is increasing evidence that shows that the epidermal barrier function is impaired in canine atopic dermatitis